RAMM Pharma (XCNQ:RAMM) Other Stockholders Equity: C$4.44 Mil (As of Jan. 2026)


What is RAMM Pharma Other Stockholders Equity?

RAMM Pharma XCNQ:RAMM Other Stockholders Equity is C$4.44 Mil as of Jan. 2026. The stock has 4 warning signs investors should review.

RAMM Pharma's Other Stockholders Equity for the quarter that ended in Jan. 2026 was C$4.44 Mil.

RAMM Pharma's quarterly Other Stockholders Equity declined from Jul. 2025 (C$4.65 Mil) to Oct. 2025 (C$4.44 Mil) and declined from Oct. 2025 (C$4.44 Mil) to Jan. 2026 (C$4.44 Mil).

RAMM Pharma's annual Other Stockholders Equity declined from Oct. 2023 (C$8.40 Mil) to Oct. 2024 (C$4.75 Mil) and declined from Oct. 2024 (C$4.75 Mil) to Oct. 2025 (C$4.44 Mil).

RAMM Pharma Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma Other Stockholders Equity Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Other Stockholders Equity
Get a 7-Day Free Trial 9.69 10.07 8.40 4.75 4.44

RAMM Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.75 4.65 4.65 4.44 4.44

RAMM Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of C$4.44 Mil mean?
RAMM Pharma (XCNQ:RAMM) has a Other Stockholders Equity of C$4.44 Mil as of Jan. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on RAMM Pharma and its competitors.
Is RAMM Pharma's Other Stockholders Equity too high?
RAMM Pharma's current Other Stockholders Equity is C$4.44 Mil.
How does RAMM Pharma's Other Stockholders Equity compare to ZTS and UTHR?
RAMM Pharma's Other Stockholders Equity of C$4.44 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on RAMM Pharma and its competitors. RAMM Pharma's current Other Stockholders Equity is C$4.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Other Stockholders Equity is C$4.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Other Stockholders Equity is C$4.44 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.